- Home
- OCUP vs HKIT Comparison
OCUP vs HKIT Comparison
Compare OCUP & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUP
- HKIT
- Stock Information
- Founded
- OCUP 2018
- HKIT 1996
- Country
- OCUP United States
- HKIT China
- Employees
- OCUP N/A
- HKIT N/A
- Industry
- OCUP Biotechnology: Pharmaceutical Preparations
- HKIT Computer Software: Prepackaged Software
- Sector
- OCUP Health Care
- HKIT Technology
- Exchange
- OCUP Nasdaq
- HKIT Nasdaq
- Market Cap
- OCUP 53.1M
- HKIT 45.4M
- IPO Year
- OCUP N/A
- HKIT 2023
- Fundamental
- Price
- OCUP $1.27
- HKIT $1.68
- Analyst Decision
- OCUP Strong Buy
- HKIT
- Analyst Count
- OCUP 3
- HKIT 0
- Target Price
- OCUP $18.67
- HKIT N/A
- AVG Volume (30 Days)
- OCUP 83.7K
- HKIT 30.7K
- Earning Date
- OCUP 11-11-2024
- HKIT 11-07-2024
- Dividend Yield
- OCUP N/A
- HKIT N/A
- EPS Growth
- OCUP N/A
- HKIT N/A
- EPS
- OCUP N/A
- HKIT 0.08
- Revenue
- OCUP $16,449,000.00
- HKIT $4,563,731.00
- Revenue This Year
- OCUP N/A
- HKIT N/A
- Revenue Next Year
- OCUP $258.69
- HKIT N/A
- P/E Ratio
- OCUP N/A
- HKIT $19.61
- Revenue Growth
- OCUP N/A
- HKIT N/A
- 52 Week Low
- OCUP $1.15
- HKIT $0.54
- 52 Week High
- OCUP $3.53
- HKIT $6.48
- Technical
- Relative Strength Index (RSI)
- OCUP 44.53
- HKIT 60.71
- Support Level
- OCUP $1.25
- HKIT $1.42
- Resistance Level
- OCUP $1.35
- HKIT $1.74
- Average True Range (ATR)
- OCUP 0.08
- HKIT 0.11
- MACD
- OCUP 0.00
- HKIT 0.02
- Stochastic Oscillator
- OCUP 12.00
- HKIT 75.86
About OCUP Ocuphire Pharma Inc.
Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.